Trials that use: Odds ratio
New to this method? Read the tutorial →
4,551 results
- An Observational Study on the Natural Course of Chronic Pancreatitis: Complete Statistical AnalysisIndependent statistical analysis of An Observational Study on the Natural Course of Chronic Pancreatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04574297).
- An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored…
- An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- An Open Label Study for Participants With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Study for Participants With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01215942).
- An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- An Open Label Trial of Bupropion and Naltrexone for Binge Drinking: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Trial of Bupropion and Naltrexone for Binge Drinking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects: Complete Statistical AnalysisIndependent statistical analysis of An Open-label Extension Study to Evaluate the Safety and Tolerability of Perampanel (E2007) Administered as an Adjunctive Therapy in Epilepsy Subjects: primary endpoint results, effect estimate with confidence…
- An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD): Complete Statistical AnalysisIndependent statistical analysis of An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD): primary endpoint results, effect estimate with…
- An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor: primary endpoint results,…
- An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area: Complete Statistical AnalysisIndependent statistical analysis of An Open-label Study of Poly-l-lactic Acid for Correction of Wrinkles in the décolletage Area: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5): Complete Statistical AnalysisIndependent statistical analysis of An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5): primary endpoint results, effect estimate with confidence interval, sample-size…
- An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041): Complete Statistical AnalysisIndependent statistical analysis of An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041):…
- An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum: Complete Statistical AnalysisIndependent statistical analysis of An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge): Complete Statistical AnalysisIndependent statistical analysis of An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV: Complete Statistical AnalysisIndependent statistical analysis of Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Analysis of Electrocorticographic Signals: Complete Statistical AnalysisIndependent statistical analysis of Analysis of Electrocorticographic Signals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03785028).
- ANCHOR-CRCIndependent statistical analysis of Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Androgen Effects on the Reproductive Neuroendocrine Axis: Complete Statistical AnalysisIndependent statistical analysis of Androgen Effects on the Reproductive Neuroendocrine Axis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06450405).
- Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1: Complete Statistical AnalysisIndependent statistical analysis of Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02574910).
- Anidulafungin In Treatment Of Candidemia In Asian Subjects: Complete Statistical AnalysisIndependent statistical analysis of Anidulafungin In Treatment Of Candidemia In Asian Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00537329).
- ANNOUNCE 2Independent statistical analysis of A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season: Complete Statistical AnalysisIndependent statistical analysis of Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 Season: primary endpoint results, effect estimate with confidence interval, sample-size…
- ANSWERIndependent statistical analysis of Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and Reconstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312856).
- Anthropometric and US-Guided Difficult Intubation Prediction With ML Models: Complete Statistical AnalysisIndependent statistical analysis of Anthropometric and US-Guided Difficult Intubation Prediction With ML Models: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06904586).
- Anti-Diabetic Medications to Fight PD and LBD: Complete Statistical AnalysisIndependent statistical analysis of Anti-Diabetic Medications to Fight PD and LBD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06263673).
- Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04225039).
- Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection: Complete Statistical AnalysisIndependent statistical analysis of Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection: primary endpoint…
- Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Anti-Tac(90 Y-HAT) to Treat Hodgkin’s Disease, Non-Hodgkin’s Lymphoma and Lymphoid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of Anti-TGF Monoclonal Antibody (GC1008) in Relapsed Malignant Pleural Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01112293).
- Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.: Complete Statistical AnalysisIndependent statistical analysis of Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS): Complete Statistical AnalysisIndependent statistical analysis of Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03261830).
- Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26: Complete Statistical AnalysisIndependent statistical analysis of Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin’s Lymphoma or Chronic Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ANTIBODY-RAIndependent statistical analysis of Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ANTICIPUSCIndependent statistical analysis of Prophylactic Noninvasive Ventilation in vs Postoperative Standard Care in High Risk Patients According to ARISCAT Score: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System: Complete Statistical AnalysisIndependent statistical analysis of Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00003508).
- Antineoplaston Therapy in Treating Patients With Meningioma: Complete Statistical AnalysisIndependent statistical analysis of Antineoplaston Therapy in Treating Patients With Meningioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00003483).
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer: Complete Statistical AnalysisIndependent statistical analysis of Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AOPDPCINVIndependent statistical analysis of Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- APAIndependent statistical analysis of Contraceptive Counseling Following an Abortion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756314).
- APACAR2Independent statistical analysis of A Comparative Study Between a Pre-hospital and an In-hospital Circulatory Support Strategy (ECMO) in Refractory Cardiac Arrest (APACAR2): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- APCGIndependent statistical analysis of Is an Antiplaque Chewing Gum (30 mg) Able to Reduce Dental Plaque in a Healthy Population?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…